Las Vegas, NV -- (SBWIRE) -- 01/13/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Yamana Gold Inc. (USA) (NYSE:AUY), AK Steel Holding Corporation (NYSE:AKS), Cell Therapeutics Inc (NASDAQ:CTIC), Sears Holdings Corp (NASDAQ:SHLD).
Yamana Gold Inc. (USA) (NYSE:AUY) ended its recent business day with the advanced of 2.94% and closed at the price of $9.10 after opening at $8.94. The stock traded during its last trading session with the total volume of 10.65 million shares, as compared to its average volume of 6.71 million shares. Yamana Gold Inc. engages in the exploration, development, and production of mineral properties, primarily gold. It also explores for copper, molybdenum, zinc, and silver metals.
Will AUY Continue To Move Higher? Find out via this report
AK Steel Holding Corporation (NYSE:AKS) remained among the day bullish 1.35% and traded with volume of 7.62 million shares in the last session, as compared to average volume of 7.16 million shares. In comparison with 52 week range of $2.76 - $8.47, it faced lowest price of $7.26 during the last trading session whereas its day highest price was $7.52. The company’s total market capitalization is $1.02 billion, along with 136.34 million shares outstanding. AK Steel Holding Corporation produces flat-rolled carbon, stainless and electrical steel, and tubular products in the United States and internationally.
Will AKS Continue To Move Higher? Find out via this report
Cell Therapeutics Inc (NASDAQ:CTIC) showed 5,100.00 shares in volume during the last trading session, while the average trading volume remained 3.29 million shares. The stock kicked off its trading session at $2.68 and closed at $2.66 after rallied 4.72%. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.
Why Should Investors Buy CTIC After The Recent Gain? Just Go Here and Find Out
Sears Holdings Corp (NASDAQ:SHLD) stock traded during its last trading session with the total traded volume of 5.61 million shares versus its average volume of 2.22 million shares. The company opened its trade at the price of $37.90 and its closing price was $36.71 after fell -13.77% for the day. Sears Holdings Corporation operates as a specialty retailer in the United States and Canada. The company’s Kmart segment operates stores that sell merchandise under Jaclyn Smith and Joe Boxer labels; and Sears brand products, such as Kenmore, Craftsman, and DieHard.
Has SHLD Found The Bottom and Ready To Move Up? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)